Trillium: 3Q Earnings Snapshot
MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Thursday reported a loss of $9.5 million in its third quarter.
The Mississauga, Ontario-based company said it had a loss of 34 cents per share. Losses, adjusted for asset impairment costs, came to 26 cents per share.
The developer of immune therapies that target cancer posted revenue of $99,200 in the period. Its adjusted revenue was $99,000.